Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Sailboatdreamon Jun 11, 2021 2:23pm
163 Views
Post# 33373344

RE:RE:RE:RE:Common Sense should prevail

RE:RE:RE:RE:Common Sense should prevail

BioTeck wrote: The same thing has been said on the videos for months. I urge you to ask them specifically what work has been completed on the regulatory package. Ask for a date when they think the package will be ready for submission. They still haven't found out if they can be fast tracked or not. Phil is too busy taking calls from ticked off investors to get anything done. They should spend less time crafting option plans and focus on the work that needs to be done. I'm glad to see others are finally realizing how bad this management team is. Use your votes.

 

I agree with Bio.  All my votes withheld until we get clear concise answers at AGM.

<< Previous
Bullboard Posts
Next >>